ІМАТИНІБ АККОРД
Analogs of ІМАТИНІБ АККОРД
Find cheaper analogs and generic equivalents for ІМАТИНІБ АККОРД.
Active Ingredient: Imatinib
Product Overview
About ІМАТИНІБ АККОРД
ІМАТИНІБ АККОРД is a medicine that contains the active ingredient Imatinib, a tyrosine-kinase inhibitor used in the treatment of certain types of cancer. It is specifically designed to target and inhibit the activity of abnormal proteins that signal cancer cells to multiply. By blocking these signals, ІМАТИНІБ АККОРД helps to slow down or stop the growth of cancer cells, providing a targeted approach to cancer treatment.
Key Benefits & Uses
- Treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML)
- Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL)
- Treatment of gastrointestinal stromal tumors (GISTs) that are c-Kit positive
Active Ingredient & Action
Imatinib, the active ingredient in ІМАТИНІБ АККОРД, works by binding to and inhibiting specific tyrosine kinases, including BCR-ABL, c-Kit, and PDGFR. This inhibition blocks the signal transduction events implicated in the proliferation and survival of cancer cells, leading to a reduction in tumor growth and an improvement in symptoms.
Important Notes
Patients taking ІМАТИНІБ АККОРД should follow the dosage and administration instructions provided by their healthcare provider. It is essential to monitor liver function, complete blood counts, and other parameters regularly during treatment. Additionally, patients should be aware of potential side effects, such as nausea, vomiting, and diarrhea, and report any concerns to their healthcare provider promptly.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.